Clinical trajectories and biological features of primary progressive aphasia (PPA)
- PMID: 19689231
- PMCID: PMC2863134
- DOI: 10.2174/156720509788929264
Clinical trajectories and biological features of primary progressive aphasia (PPA)
Abstract
Primary Progressive Aphasia (PPA) is a neurodegenerative syndrome characterized by a gradual dissolution of language, but relative sparing of other cognitive domains during the initial stages of the disease. Research has led to substantial progress in understanding the clinical characteristics, genetics, and neuropathology of this syndrome. This article reviews the clinical criteria for diagnosing PPA, discusses the utility of defining the mild cognitive impairment (MCI) stage of PPA, and highlights some of the more recent research advances particularly in the area of pathology and genetics.
Figures
References
-
- Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11(6):592–8. - PubMed
-
- Mesulam MM. Primary progressive aphasia--differentiation from Alzheimer's disease [editorial] Ann Neurol. 1987;22(4):533–4. - PubMed
-
- Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006;20(4):210–6. - PubMed
-
- Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration. A consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54. - PubMed
-
- Miller BL, Boone K, Geschwind DH. Pick's disease and frontotemporal dementias: Emerging clinical and molecular concepts. Neurologist. 1999;5:205–12.
